Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Chengappa, K. N. R.
Nimgaonkar, V. L.
Bachert, C.
Yang, Z.W.
Rabin, B. S.
and
Ganguli, R.
1995.
Obstetric complications and autoantibodies in schizophrenia.
Acta Psychiatrica Scandinavica,
Vol. 92,
Issue. 4,
p.
270.
Hanisch, Uwe-Karsten
and
Quirion, Rémi
1995.
Interleukin-2 as a neuroregulatory cytokine.
Brain Research Reviews,
Vol. 21,
Issue. 3,
p.
246.
Rogers, Malcolm P.
and
Fozdar, Manish
1996.
Psychoneuroimmunology of autoimmune disorders.
Advances in Neuroimmunology,
Vol. 6,
Issue. 2,
p.
169.
Schott, K.
Batra, A.
Uhl, A.
Bartels, M.
and
Buchkremer, G.
1997.
Current Update in Psychoimmunology.
p.
99.
Leykin, I.
Mayer, R.
and
Shinitzky, M.
1997.
Short and long term immunosuppressive effects of clozapine and haloperidol.
Immunopharmacology,
Vol. 37,
Issue. 1,
p.
75.
Shinitzky, M.
Leykin, I.
and
Dcckmann, M.
1999.
The Decade of Autoimmunity.
p.
277.
Yovel, Galit
Sirota, Pinkhas
Mazeh, Doron
Shakhar, Guy
Rosenne, Ella
and
Ben-Eliyahu, Shamgar
2000.
Higher Natural Killer Cell Activity in Schizophrenic Patients: The Impact of Serum Factors, Medication, and Smoking.
Brain, Behavior, and Immunity,
Vol. 14,
Issue. 3,
p.
153.
Rothermundt, Matthias
Arolt, Volker
and
Bayer, Thomas A.
2001.
Review of Immunological and Immunopathological Findings in Schizophrenia.
Brain, Behavior, and Immunity,
Vol. 15,
Issue. 4,
p.
319.
Hinze-Selch, Dunja
and
Pollmächer, Thomas
2001.
In Vitro Cytokine Secretion in Individuals with Schizophrenia: Results, Confounding Factors, and Implications for Further Research.
Brain, Behavior, and Immunity,
Vol. 15,
Issue. 4,
p.
282.
Pearce, B D
2001.
Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms.
Molecular Psychiatry,
Vol. 6,
Issue. 6,
p.
634.
Schwarz, Markus J.
Chiang, Sonnig
Müller, Norbert
and
Ackenheil, Manfred
2001.
T-helper-1 and T-helper-2 Responses in Psychiatric Disorders.
Brain, Behavior, and Immunity,
Vol. 15,
Issue. 4,
p.
340.
Borda, Tania
Perez Rivera, Ricardo
Joensen, Lilian
Gomez, Ricardo M.
and
Sterin-Borda, Leonor
2002.
Antibodies Against Cerebral M1 Cholinergic Muscarinic Receptor from Schizophrenic Patients: Molecular Interaction.
The Journal of Immunology,
Vol. 168,
Issue. 7,
p.
3667.
Gaughran, Fiona
2002.
Neurobiology of the Immune System.
Vol. 52,
Issue. ,
p.
275.
Giovannoni, Gavin
and
Baker, David
2003.
Inflammatory disorders of the central nervous system.
Current Opinion in Neurology,
Vol. 16,
Issue. 3,
p.
347.
Wang, Xiao-Fen
Wang, Dunrui
Zhu, Weiguo
Delrahim, Katia K
Dolnak, Douglas
and
Hyman Rapaport, Mark
2003.
Studies characterizing 60 kda autoantibodies in subjects with schizophrenia.
Biological Psychiatry,
Vol. 53,
Issue. 5,
p.
361.
Pollmächer, Thomas
Schuld, Andreas
and
Hinze-Selch, Dunja
2003.
Cytokines and Mental Health.
Vol. 7,
Issue. ,
p.
339.
Schwarz, Markus J.
2003.
Cytokines, neurophysiology, neuropsychology, and psychiatric symptoms..
Dialogues in Clinical Neuroscience,
Vol. 5,
Issue. 2,
p.
139.
Schuld, A.
Hinze-Selch, D.
and
Pollmächer, Th.
2004.
Zytokinnetzwerke bei Patienten mit Schizophrenie und ihre Bedeutung für die Pathophysiologie der Erkrankung.
Der Nervenarzt,
Vol. 75,
Issue. 3,
p.
215.
Riedel, Michael
Strassnig, Martin
Schwarz, Markus J
and
M??ller, Norbert
2005.
COX-2 Inhibitors as Adjunctive Therapy in Schizophrenia.
CNS Drugs,
Vol. 19,
Issue. 10,
p.
805.
Jones, Amanda L
Mowry, Bryan J
Pender, Michael P
and
Greer, Judith M
2005.
Immune dysregulation and self‐reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis?.
Immunology & Cell Biology,
Vol. 83,
Issue. 1,
p.
9.